Results 261 to 270 of about 136,665 (362)

Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE‐303 Open‐Label Study

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Etripamil is a fast‐acting intranasally self‐administered calcium‐channel blocker developed for termination of paroxysmal supraventricular tachycardia (PSVT). Prior studies have demonstrated safety and efficacy of etripamil for PSVT termination following an initial medically supervised test dose during sinus rhythm. NODE‐303 is an
James E. Ip, Benoit Coutu, John H. Ip, Peter A. Noseworthy, Maria L. Parody, Farhad Rafii, Samuel F. Sears, Narendra Singh, Bruce S. Stambler, Naeem K. Tahirkheli, Juan Agudelo‐Uribe, Derek Hu, Silvia Shardonofsky, Muhammad B. Sheikh, Anita Holz, David B. Bharucha, A. John Camm   +16 more
wiley   +1 more source

Successful implantation of cardiac resynchronization therapy in a patient with coronary sinus reducer using proximal coronary sinus branches: a case report. [PDF]

Eur Heart J Case Rep
Costantino J, Zuccaro LM, Romani B, Rotolo FL, Porcelli D.   +4 more
europepmc   +1 more source

AIV-4 Myocardial oxygen consumption and coronary sinus flow following left ventricular aneurysmectomy

, 1984
河内 寛治, 北村 惣一郎, 大山 朝賢, 康 重雄, 宮城 康夫, 森田 隆一, 山田 義帰, 広瀬 一, 中埜 粛, 川島 康生   +9 more
openalex   +2 more sources

Ethanol Infusion in the Vein of Marshall for Persistent Atrial Fibrillation Ablation: Evidence From Randomized Controlled Trials

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation (CA) for atrial fibrillation (AF), yet outcomes remain suboptimal in persistent AF patients. Ethanol infusion in the vein of Marshal (VoM), an embryological remnant implicated in AF pathogenesis, may enhance ablation efficacy.
Carolina Saleiro, Sérgio Barra, Bárbara Oliveiros, Patrícia Alves, João Ferreira, Natália António, Luís Elvas, Lino Gonçalves, Miguel Valderrábano, Pedro A. Sousa   +9 more
wiley   +1 more source

The Beck Procedure Revisited: Percutaneous Approach to Myocardial Perfusion Through the Coronary Sinus. [PDF]

JACC Case Rep
Alaswad K, O'Neill WO, Nakhle A, Koenig GC, Fuller BS, Wang DD.   +5 more
europepmc   +1 more source

Total anomalous pulmonary venous drainage by double connection corrected by ascending vein and coronary sinus repair; To the Editor:

, 1993
Henry J.C.M. van de Wal
openalex   +1 more source

Visualization of Real‐Time Esophageal Location Using Intracardiac Echocardiography on a Three‐Dimensional Mapping System: Comparison of Esophageal Location Using Preoperative Computed Tomography and Investigation of Predictors for Esophageal Movement During Catheter Ablation

Journal of Cardiovascular Electrophysiology, EarlyView.
Esophageal imaging using intracardiac echocardiography (ICE‐Eso) showed a more accurate real‐time esophageal location than preoperative computed tomography (CT‐Eso). Non‐fasting on the day of catheter ablation (CA) may be a predictor of esophageal movement on the day of CA.
Koji Sudo, Kenji Kuroki, Chisa Asahina, Maoko Atsumi, Kazuya Nakagawa, Tetsuya Asakawa, Tomoaki Hasegawa, Kazutaka Aonuma, Akira Sato   +8 more
wiley   +1 more source

Dual Sinus Origins of the Left Coronary Artery From the Right and Left Coronary Sinus. [PDF]

CJC Open
Oliveri F, Van Oort M, Van der Kley F, Jukema JW, Montero-Cabezas J.   +4 more
europepmc   +1 more source

The effect of intermittent coronary sinus occlusion on coronary sinus pressure dynamics and coronary arterial flow.

, 1992
Hironobu Matsuhashi, Naoyuki Hasebe, Yuichiro Kawamura   +2 more
openalex   +2 more sources

Lesion Depth Optimization in High‐Power Radiofrequency Ablation: Evaluating Single High‐Power and Combined Very High‐Power Applications

Journal of Cardiovascular Electrophysiology, EarlyView.
Lesions were significantly deeper with very high‐power short‐duration (vHPSD) ablation followed by a target ablation index (AI) of 450 compared to double vHPSD ablations in an ex vivo model. However, a high‐power application with a target AI of 550 produced significantly deeper lesions than vHPSD + AI 450 in an in vivo model. ABSTRACT Background A very
Hidehiro Iwakawa, Masateru Takigawa, Ryosuke Kato, Junji Yamaguchi, Masaki Honda, Ryo Tateishi, Miho Negishi, Iwanari Kawamura, Kentaro Goto, Takuro Nishimura, Kazuya Yamao, Susumu Tao, Sayaka Suzuki, Takehiro Iwanaga, Shinsuke Miyazaki, Hiroyuki Watanabe, Tetsuo Sasano   +16 more
wiley   +1 more source